Metabolic syndrome in the indigenous population of Yakutia
Abstract
In the article prevalence and clinical variants of a metabolic syndrome among the native population of Yakutia are considered. On an example of type 2 diabetes in representatives of the Yakut population a role of a metabolic syndrome and system inflammatory process in development of a somatic pathology is discussed. Results of genetic researches of polymorphic variants of genes (LPL, IL6, RSTN, ABCC8), causing predisposition of the Yakut population representatives to development of metabolic disturbances, insulin resistance and to disease by type 2 diabetes are presented.
About the Authors
V. L. OsakovskijРоссия
L. G. Goldfarb
Соединённые Штаты Америки
T. M. Klimova
Россия
N. Sambuugin
Соединённые Штаты Америки
Z. Odgerel
Соединённые Штаты Америки
M. N. Yakovleva
Россия
P. M. Ignatiev
Россия
L. L. Alexeeva
Россия
M. E. Baltakhinova
Россия
G. A. Timofeev
Россия
V. G. Krivoshapkin
Россия
F. A. Platonov
Россия
References
1. Козлов А.И. Физиолого-биохимические и антропоэкологические основы жизнедеятельности человека на Севере / А.И. Козлов, Е.Р. Бойко / Материалы II Северного социальноэкологического конгресса «Горизонты экономического и культурного развития», 19-21 апреля 2006 г., г. Сыктывкар, Республика Коми. – http://congress-syktyvkar.ru/download/2congress/kozlov_boiko.doc
2. Либерман И.С. Метаболический синдром в свете эволюционно-генетических закономерностей / И.С. Либерман // Российский кардиологический журнал. – 2002. – N 1.
3. Панин Л.Е. Энеpгетические аспекты адаптации / Л.Е. Панин. – Л.: Медицина, 1978.
4. Проблемы поздней диагностики сахарного диабета 2 типа у якутов / П.М. Игнатьев, Л.П. Алексеева, В.Г. Кривошапкин и др. // Якутский медицинский журнал. - 2009. - №1(25). - С.79-82.
5. Activating mutation in the ABCC8 gene in neotanal diabetes mellitus / A.P. Babenko et all] // The New England journal of medicine. 2006. 355: 456-466
6. Ashcroft F.M. ATP-sensitive K+ channels and disease: from molecule to malady / Frances M. Ashcroft // Am. J. Physiol. Endocrinol Metab. 2007. 293: E880-E889.
7. Berg A.H. Adipose tissue, Inflammation, and Cardiovascular disease / Anders H. Berg, Philipp E. Scherer // Circulation Research. 2005. 96: 939-949.
8. Caro F. Jose. Insulin resistance in Obese and Nonobese Man // J Clin Endocrinol Metabolism. 1991. 73: 691-695.
9. Cardiovascular morbidity and mortality associated with the metabolic syndrome (Botnia Study) / B. Isomaa, P. Almgren, T. Tuomi, et all //Diab Car. 2001. N 24. P. 683–689.
10. Clauser E. Molecular Basis of Insulin Resistance / E. Clauser, I. Leconte, C. Auzan // Hormone Researche. 1992. 38: 5-12.
11. Fontbonne A. The Insulin resistance Syndrome and the Paris Prospective Study / A. Fontbonne, A. Charli // Cardiovascular Risk Factors. 1993. 3: 36-43.
12. Ford E.S. Prevalence of the metabolic syndrome among US adults / E.S. Ford, W.H Giles, W.H Dietz // JAMA. 2002. N 287. P. 356-359.
13. Gloyn A.L. Large-scale association studies of variants in genes encoding the pancreatic-cell K+ATP channel subunits Kir6.2 (KCNJ11 E23K variant is associated with type 2 diabetes / A.L. Gloyn // Diabetes. – 2003. – 52: 568-572.
14. Guilherme A. TNFα decreases triglyceride deposition and increases lipolysis in adipose cells / Adilson Guilherme [et al.] // Nature Reviews Molecular cell biology. 2008. 9: 367-377.
15. Hanefeld M. The metabolic syndrome and its epidemiologic dimensions in historical perspective / M. Hanefeld, C. Kohler // Z Arztl Fortbild Qualitats. 2002. N 96. S. 183-188.
16. Insulin resistance in Type 2 (non-insulindependent) diabetic patients with hypertriglyceridemia / E. Widen, A. Ekstrand, C. Saloranta [et al.] // Diabetologia. 1992. 35: 1140-1145.
17. Jia W. P. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China / W. P. Jia, K.S Xiang, L. Chen // Obes Rev. 2002. N 3. P.157-165.
18. Klein B. E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam / B. E. Klein, R. Klein, K.E. Lee // Diab Car. 2002. N 25. P. 1790-1794.
19. Lakka H. M. The metabolic syndrome and total cardiovascular disease mortality in middle aged men / H. M. Lakka, D. E. Laaksonen, T.A Lakka // JAMA. 2002. N 288. P. 2709-2716.
20. Lipoprotein (a) and coronary heart disease: a prospective case-control study in general population sample of middle aged men / A. Rosengren, L. Wilhelmsen, E. Ericson [et al.] // Br Med J. 1990. 301: 1248-1251.
21. Peripheral mononuclear cell resistin mRNA expression is increased in type 2 Diabetic women / P.C. Tsiotra, C. Tsigov [et al.] // Published online. 2008. December 21. doi: 1155/2008/892864
22. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers / P. Marques-Vidal, E. Mazoyer, V. Bongard, et all // Diab Car. 2002. N 25. Р. 1371-1377.
23. Reaven J.M. Banting lecture: Role of insulin resistence in human disease / J.M. Reaven // Diabetes. 1988. Vol. 37. P. 1595-1607.
24. Scott L.J. / A genome-wide association study of type 2 diabetes in Finns defect multiple susceptibility variants / L.J. Scott [et al.] // Science. 2007. 26. April.
25. Study of lipoprotein lipase gene intron 8 polymorphisms in Chinese Han race essential hypertension patients / Xin Tu, Jinwen Tu, Xiuying Wen [et al.] // Cardiology. 2005. Vol.99, Issue 2, Pages 263-267.
26. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects / Karene Clement [et al.] // The FASEB Journal. 2004. 18: 1657-1669.
Review
For citations:
Osakovskij V.L., Goldfarb L.G., Klimova T.M., Sambuugin N., Odgerel Z., Yakovleva M.N., Ignatiev P.M., Alexeeva L.L., Baltakhinova M.E., Timofeev G.A., Krivoshapkin V.G., Platonov F.A. Metabolic syndrome in the indigenous population of Yakutia. Yakut Medical Journal. 2010;(2):98-102. (In Russ.)
JATS XML









